181 related articles for article (PubMed ID: 36142223)
21. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.
Su K; Peng Y; Yu H
Dis Markers; 2022; 2022():9141117. PubMed ID: 35677632
[TBL] [Abstract][Full Text] [Related]
22. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
Front Immunol; 2021; 12():769425. PubMed ID: 34804059
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma.
Luo L; Zhang G; Wu T; Wu G
Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547
[TBL] [Abstract][Full Text] [Related]
26. High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma.
Liu Q; Bai Y; Shi X; Guo D; Wang Y; Wang Y; Guo WZ; Zhang S
Sci Rep; 2022 Oct; 12(1):17492. PubMed ID: 36261459
[TBL] [Abstract][Full Text] [Related]
27. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
[TBL] [Abstract][Full Text] [Related]
28. Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma.
Wu Z; Huang X; Cai M; Huang P; Guan Z
Aging (Albany NY); 2022 Jan; 14(2):869-891. PubMed ID: 35077391
[TBL] [Abstract][Full Text] [Related]
29. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S
Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864
[TBL] [Abstract][Full Text] [Related]
30. Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma.
Zhang LL; He QK; Lv YN; Zhang ZJ; Xiang YK
Chronobiol Int; 2021 May; 38(5):681-693. PubMed ID: 33691542
[TBL] [Abstract][Full Text] [Related]
31. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research.
Bai Z; Xu F; Feng X; Wu Y; Lv J; Shi Y; Pei H
Bioengineered; 2022 Jan; 13(1):1717-1735. PubMed ID: 35000541
[TBL] [Abstract][Full Text] [Related]
32. Classification and Prognosis Analysis of Pancreatic Cancer Based on DNA Methylation Profile and Clinical Information.
Li X; Zhang X; Lin X; Cai L; Wang Y; Chang Z
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292798
[TBL] [Abstract][Full Text] [Related]
33. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
34. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
Front Genet; 2022; 13():848391. PubMed ID: 35601487
[No Abstract] [Full Text] [Related]
35. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma.
Deng J; Zhang Q; Lv L; Ma P; Zhang Y; Zhao N; Zhang Y
Sci Rep; 2022 Apr; 12(1):7006. PubMed ID: 35488119
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
[TBL] [Abstract][Full Text] [Related]
37. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma.
Li Y; Su Z; Wei B; Liang Z
Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523
[TBL] [Abstract][Full Text] [Related]
38. The NT5DC family: expression profile and prognostic value in pancreatic adenocarcinoma.
Yu X; Sun R; Yang X; He X; Guo H; Ou C
J Cancer; 2023; 14(12):2274-2288. PubMed ID: 37576396
[TBL] [Abstract][Full Text] [Related]
39. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma.
Dai L; Mugaanyi J; Cai X; Lu C; Lu C
Sci Rep; 2022 Jul; 12(1):11944. PubMed ID: 35831362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
